{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:47:48Z","timestamp":1783532868659,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"crossref","award":["2019YFS0538"],"award-info":[{"award-number":["2019YFS0538"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070690"],"award-info":[{"award-number":["82070690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Lipoprotein glomerulopathy (LPG) is a rare glomerular disease characterized by the deposition of lipoprotein thrombi in glomerular capillaries. The disease is characterized by proteinuria, progressive renal failure, and characteristic lipoprotein thrombosis in glomerular capillaries. Rare mutations in the apolipoprotein E (<jats:italic toggle=\"yes\">APOE<\/jats:italic>) gene mainly contribute to disease pathogenesis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 28-year-old man presented with severe proteinuria and hyperlipidemia. The patient was treated with a full dose of prednisone for 2\u200amonths and then combined with leflunomide 20\u200amg daily for 20\u200adays; however, his edema continued to worsen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The patient was diagnosed LPG by laboratory examination and renal biopsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with atorvastatin (20\u200amg) combined with irbesartan (75\u200amg) once a day.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient's lipidaemia and proteinuria were significantly reduced. Genetic testing showed that the patient carried compound heterozygous mutations in <jats:italic toggle=\"yes\">APOE<\/jats:italic>. <jats:italic toggle=\"yes\">The APOE<\/jats:italic> gene was inherited from her mother and father. Parents with a heterogeneous mutation had normal kidney function without proteinuria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Usually, a single mutation in <jats:italic toggle=\"yes\">APOE<\/jats:italic> can lead to the pathogenesis of LPG. This case shows that LPG could result from compound heterogeneous mutations of <jats:italic toggle=\"yes\">the APOE<\/jats:italic> gene inherited from his mother and father. Intensive lipid-lowering combined with RASIs is effective in patients with LPG. Early renal biopsy and genetic mutation detection can avoid the unnecessary use of glucocorticoids and immunosuppressants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028718","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:04:00Z","timestamp":1643979840000},"page":"e28718","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4189-5918","authenticated-orcid":false,"given":"Yunsi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.kint.2019.10.031","article-title":"Apolipoprotein E-related glomerular disorders","volume":"97","author":"Saito","year":"2020","journal-title":"Kidney Int"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0046-8177(87)80238-1","article-title":"Renal lipidoses: a review","volume":"18","author":"Faraggiana","year":"1987","journal-title":"Hum Pathol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0272-6386(89)80134-9","article-title":"Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia","volume":"13","author":"Saito","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ndt\/13.5.1292","article-title":"Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation","volume":"13","author":"Mourad","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1681\/ASN.V1071590","article-title":"Apolipoprotein E2\/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney","volume":"10","author":"Miyata","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1523-1755.1999.00677.x","article-title":"A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy","volume":"56","author":"Ando","year":"1999","journal-title":"Kidney Int"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","article-title":"A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy","volume":"56","author":"Matsunaga","year":"1999","journal-title":"Kidney Int"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc072088","article-title":"APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy","volume":"357","author":"Rovin","year":"2007","journal-title":"N Engl J Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/ndt\/gfq389","article-title":"A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy","volume":"25","author":"Bomback","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0272-6386(12)80649-4","article-title":"Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy","volume":"18","author":"Oikawa","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s004670050264","article-title":"Lipoprotein glomerulopathy: a pediatric case report","volume":"11","author":"Maruyama","year":"1997","journal-title":"Pediatric Nephrol (Berlin, Germany)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0272-6386(95)90581-2","article-title":"Lipoprotein glomerulopathy with a new apolipoprotein E phenotype","volume":"25","author":"Komatsu","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000044933","article-title":"Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population","volume":"78","author":"Yang","year":"1998","journal-title":"Nephron"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ndt\/10.4.546","article-title":"Lipoprotein glomerulopathy: first case in a white European","volume":"10","author":"Meyrier","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"733","DOI":"10.5551\/jat.41996","article-title":"The novel apolipoprotein E mutation ApoE Chengdu (c.518T>C, p. L173P) in a Chinese patient with lipoprotein glomerulopathy","volume":"25","author":"Wu","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000111828","article-title":"Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy","volume":"28","author":"Luo","year":"2008","journal-title":"Am J Nephrol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/CM9.0000000000000050","article-title":"A novel apolipoprotein E mutation (p.Arg150Cys) in a Chinese patient with lipoprotein glomerulopathy","volume":"132","author":"Ku","year":"2019","journal-title":"Chin Med J"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5414\/CN106876","article-title":"A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy","volume":"78","author":"Liao","year":"2012","journal-title":"Clin Nephrol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ki.2013.335","article-title":"Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation","volume":"85","author":"Hu","year":"2014","journal-title":"Kidney Int"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ki.2013.404","article-title":"Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis","volume":"85","author":"Saito","year":"2014","journal-title":"Kidney Int"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","article-title":"Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases","volume":"47","author":"Saito","year":"2006","journal-title":"Am J Kidney Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:05Z","timestamp":1746331625000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028718"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028718","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"assertion":[{"value":"2021-11-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}